Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System

H D Blasey1, B Brethon, R Hovius

  • 1Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, CH-1228, Plan-les-Ouates, Switzerland, horst.blasey@serono.com.

Cytotechnology
|November 13, 2008
PubMed
Summary

The Semliki Forest Virus (SFV) system successfully scaled up recombinant protein production to bioreactor levels, achieving high yields of functional human 5-HT(3) receptors. Optimization, including pH control, doubled expression levels for efficient large-scale applications.

Related Concept Videos